3 unknown, 1 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Completed 1 |
Follow Lobeline: new trials by email Literature Review of Lobeline trials Research Report on Lobeline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients Lobeline sulfate, Methylphenidate HCl, Placebo - Attention Deficit Disorder With Hyperactivity | Phase 2 | Completed | Yaupon Therapeutics | 13 | 2008-07-01 | 2013-06-20 |
| Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 Lobeline - Methamphetamine Dependence | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 12 | 2006-02-01 | 2017-01-11 |
| To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 Lobeline - Amphetamine-Related Disorders | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 8 | 2004-09-01 | 2017-01-11 |
| Ph1 Lobeline Interaction Study - 1 Lobeline - Methamphetamine Dependence | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 10 | 2017-01-11 |
Amphetamine-Related Disorders (1) · Attention Deficit Disorder with Hyperactivity (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Dyskinesias (1) · Hyperkinesis (1) · Neurodevelopmental Disorders (1) · Neurologic Manifestations (1)
National Institute on Drug Abuse (NIDA) (3) · Yaupon Therapeutics (1)
United States (4)
Reese Jones, M.D. (3) · Catherine A. Martin, MD (1)
R43MH081553 (1)